Dr Markus Weissbach has been named as the new Chief Operating Officer of Irish drug discovery and development company DS Biopharma. He is currently Medical Director of of the company and takes up his new role with immediate effect.
Dr Weissbach has more than 25 years’ experience in the international pharmaceutical, biotech and CRO industry. His previous appointments include Chief Medical Officer (Europe) at Novartis Vaccines and Diagnostics; Executive Chairman, CEO and President of Averion International Corp; President of ICON Clinical Research Plc. (Europe); Director of Clinical Research and Development at Takeda R&D (Europe) and International Medical Director at Knoll.
